The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria
Pain
.
2021 Sep 1;162(9):2346-2348.
doi: 10.1097/j.pain.0000000000002245.
Authors
Andreas Goebel
1
,
Frank Birklein
2
,
Florian Brunner
3
,
J David Clark
4
,
Janne Gierthmühlen
5
,
Norman Harden
6
,
Frank Huygen
7
,
Lone Knudsen
8
,
Candy McCabe
9
,
Jenny Lewis
9
10
,
Christian Maihöfner
11
,
Walter Magerl
12
,
G Lorimer Moseley
13
,
Astrid Terkelsen
14
,
Ilona Thomassen
15
,
Stephen Bruehl
16
Affiliations
1
Department of Pain Medicine, Pain Research Institute, University of Liverpool and Walton Centre NHS Foundation Trust Liverpool, United Kingdom.
2
Department of Neurology, University of Mainz, Mainz, Germany.
3
Department of Physical Medicine and Rheumatology, Balgrist University Clinic, Zurich, Switzerland.
4
Stanford University School of Medicine, Stanford, CA, United States.
5
Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital of Schleswig-Holstein Campus Kiel, Kiel, Germany.
6
NorthWestern University, Chicago, IL, United States.
7
Rotterdam University, Rotterdam, the Netherlands.
8
The National Rehabilitation Center for Neuromuscular Diseases, Aarhus, Denmark.
9
School for Health and Social Wellbeing, University of the West of England, Bristol, United Kingdom.
10
Royal United Hospitals Bath NHS Trust, Bath University, Bath, United Kingdom.
11
Neurologische Klinik, Klinikum Fuerth, Fuerth, Germany.
12
University of Heidelberg, Mannheim Germany.
13
University of South Australia, Australia.
14
Department of Neurology, Danish Pain Research Center, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
15
Patiëntenvereniging CRPS, Nijmegen, the Netherlands.
16
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, United States.
PMID:
33729210
PMCID:
PMC8374712
DOI:
10.1097/j.pain.0000000000002245
No abstract available
MeSH terms
Complex Regional Pain Syndromes* / diagnosis
Consensus
Diagnosis, Differential
Humans
Grants and funding
21503/VAC_/Versus Arthritis/United Kingdom